Kaléo
Kaléo is a healthcare company that develops innovative solutions, including the Aerio™ Auto-Injector Platform, and holds over 200 issued patents. The company is dedicated to enhancing patient lives and manufactures its products in the United States.
Innovative Healthcare Solutions by Kaléo
Kaléo develops innovative healthcare solutions designed to empower patients and help them live fuller, bolder lives. The company's strategic vision is to create a world where every person has access to advanced healthcare options.
Kaléo's Next-Generation Countermeasure Development
Kaléo was awarded a contract by the U.S. Department of Health and Human Services to develop a next-generation countermeasure for organophosphate nerve agent poisoning. This project highlights Kaléo's commitment to addressing critical healthcare challenges.
Aerio™ Auto-Injector Platform by Kaléo
Kaléo offers the Aerio™ Auto-Injector Platform, which features proprietary gas-powered technology for efficient drug delivery. This platform underscores Kaléo's dedication to innovation in medical device technology.
Kaléo Intellectual Property Portfolio
Kaléo holds an extensive intellectual property portfolio with over 200 issued patents. This robust patent portfolio showcases the company's ongoing commitment to research, development, and innovation in healthcare solutions.
US-based Manufacturing and Quality at Kaléo
Kaléo is committed to manufacturing its products in the United States, prioritizing high device reliability and quality. This dedication to domestic production reflects the company's focus on maintaining superior manufacturing standards.